Medicamen Biotech Q3 Results

  • BSE: 531146
  • NSE: MEDICAMEQ
  • ISIN: INE646B01010
  • Sector: Biotechnology & Drugs
BSE
442.7-5.35 (-1.19%)
Volume1.24 K
Updated: Mon 25 Nov, 2024 | 15:28:51
NSE
435.1-11.65 (-2.61%)
Volume23.85 K
Updated: Mon 25 Nov, 2024 | 15:29:47
Today: 434.70
456.85
52-Wk: 356.75
661.85

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Medicamen Biotech Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 46.5085.48-%35.58-%
    Selling/ General/ Admin Expenses Total 8.0113.66-%5.67-%
    Depreciation/ Amortization 1.803.51-%1.60-%
    Other Operating Expenses Total 8.6216.21-%7.06-%
    Total Operating Expense 43.4177.40-%31.31-%
    Operating Income 3.098.08-%4.28-%
    Net Income Before Taxes 3.277.15-%4.22-%
    Net Income 2.036.77-%3.76-%
    Diluted Normalized EPS 1.604.90-%2.98-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts